Literature DB >> 17148671

Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

Gudrun Szalay1, Martina Sauter, Joachim Hald, Andreas Weinzierl, Reinhard Kandolf, Karin Klingel.   

Abstract

Ongoing coxsackievirus B3 (CVB3) myocarditis is characterized by persistence of viral RNA and chronic inflammation primarily mediated by macrophages and T cells. Activated macrophages produce anti-viral effector molecules comprising reactive nitrogen intermediates; however, reactive nitrogen intermediates also contribute to host tissue damage. Controlled activation of macrophages depends on interferon (IFN)-gamma and interleukin (IL)-10. To evaluate mechanisms involved in CVB3-induced pathogenesis of myocarditis, we determined the relationship of inducible nitric-oxide synthase (iNOS) mRNA expression with IFN-gamma and IL-10 secretion during CVB3 infection in different mouse strains. We found in susceptible A.BY/SnJ mice that develop ongoing myocarditis, a low and delayed IFN-gamma secretion and highly diminished IL-10 production compared with resistant C57BL/6 mice. Consequently, iNOS mRNA synthesis was delayed but clearly prolonged in susceptible mice. IL-10 gene-deficient mice confirmed the regulatory role of IL-10 in the outcome of CVB3 myocarditis. These mice did not establish a persistent cardiac infection and revealed IFN-gamma secretion kinetics similar to resistant mice but showed a slightly elongated cardiac iNOS mRNA expression resulting in extended myocarditis. We conclude that coordinated secretion of IFN-gamma and IL-10 is crucial for the effective resolution of CVB3 myocarditis. Moreover, lack of regulatory IL-10 leads to uncontrolled iNOS mRNA production, thus contributing to ongoing myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148671      PMCID: PMC1762471          DOI: 10.2353/ajpath.2006.060350

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice.

Authors:  M R Capobianchi; D Matteucci; A Giovannetti; E Soldaini; M Bendinelli; J G Stanton; F Dianzani
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

2.  Treatment of experimental viral myocarditis with interleukin-10.

Authors:  R Nishio; A Matsumori; T Shioi; H Ishida; S Sasayama
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

Review 3.  Viral infection and the pathogenesis of dilated cardiomyopathy.

Authors:  T A Martino; P Liu; M J Sole
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

4.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells.

Authors:  R Kandolf; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury.

Authors:  L H Chow; K W Beisel; B M McManus
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

7.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis.

Authors:  Mototsugu Nishii; Takayuki Inomata; Hitoshi Takehana; Ichiro Takeuchi; Hironari Nakano; Toshimi Koitabashi; Jun-ichi Nakahata; Naoyoshi Aoyama; Tohru Izumi
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

9.  Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; J F Martin
Journal:  Br Heart J       Date:  1995-10
View more
  21 in total

1.  Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2012-03-11       Impact factor: 3.616

2.  Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.

Authors:  Sandra Jäkel; Ulrike Kuckelkorn; Gudrun Szalay; Michael Plötz; Kathrin Textoris-Taube; Elisa Opitz; Karin Klingel; Stefan Stevanovic; Reinhard Kandolf; Katja Kotsch; Karl Stangl; Peter M Kloetzel; Antje Voigt
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

3.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

4.  Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.

Authors:  Ya-Qian Huang; Hong-Fang Jin; Heng Zhang; Chao-Shu Tang; Jun-Bao Du
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

6.  Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.

Authors:  Fabian Freiberg; Martina Sauter; Sandra Pinkert; Thirupugal Govindarajan; Joanna Kaldrack; Meghna Thakkar; Henry Fechner; Karin Klingel; Michael Gotthardt
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

7.  Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.

Authors:  Andreas Oliver Weinzierl; Gudrun Szalay; Hartwig Wolburg; Martina Sauter; Hans-Georg Rammensee; Reinhard Kandolf; Stefan Stevanović; Karin Klingel
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

Review 8.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

Review 9.  Management of inflammation in cardiovascular diseases.

Authors:  Sumanta Kumar Goswami; Prabhat Ranjan; Roshan Kumar Dutta; Suresh Kumar Verma
Journal:  Pharmacol Res       Date:  2021-09-23       Impact factor: 7.658

10.  Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.

Authors:  Irene Müller; Lisa Janson; Martina Sauter; Kathleen Pappritz; Sophie Van Linthout; Carsten Tschöpe; Karin Klingel
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.